logo

For the Inventor, By the Inventor

Solna, Sweden

Affibody Ab


USPTO Granted Patents = 41

% Expired Patents = 9.8



Trademarks = 1

Forward Citations = 148

Loading Chart...
Loading Chart...

55 inventors (with patents filed for the assignee):

goldMedal Elin Gunneriusson (13 out of 20 patents)

silverMedal Fredrik Frejd (11 out of 12 patents)

bronzeMedal Joachim Feldwisch (10 out of 16 patents)

4.  Christofer Lendel (10 out of 12 patents)

5.  Nina Herne (9 out of 10 patents)

6.  Lars Abrahmsén (9 out of 9 patents)

7.  Caroline Ekblad (8 out of 8 patents)

8.  Lars B Abrahmsen (7 out of 19 patents)

9.  Andreas Jonsson (6 out of 6 patents)

10.  Tove Eriksson (5 out of 5 patents)

11.  Stefan Ståhl (4 out of 5 patents)

12.  Lindvi Gudmundsdotter (4 out of 4 patents)

13.  Malin Lindborg (4 out of 10 patents)

14.  John Löfblom (4 out of 5 patents)

15.  Torbjörn Gräslund (4 out of 4 patents)


Core Competencies:
IL-17A Associated Conditions
HER2 Binders
Binding Polypeptides
Polypeptide Libraries
Neonatal Fc Receptor Binding
Engineered Albumin Binding
Polypeptides Having Affinity for HER2
IGF-1R Binding Polypeptides
Affinity Separation
Protein A Derivatives
Staphylococcus Protein A Domain Mutants
In Vitro Selection of Polypeptides

41 patents:

1. 12653913 - HER2 BINDERS (2026-06-16),
2. 12221464 - Methods of treatment of IL-17A associated conditions (2025-02-11),
3. 11633507 - HER2 binders (2023-04-25),
4. RE49495 - Binding polypeptides having a mutated scaffold (2023-04-17),
5. 11505576 - Polypeptides based on a scaffold (2022-11-22),
6. 11155596 - Polypeptide (2021-10-26),
7. 10934335 - IL-17A-binding polypeptides (2021-03-02),
8. 10894097 - HER2 binders (2021-01-19),
9. 10669314 - Polypeptide (2020-06-02),
10. 10633423 - IL-6-binding polypeptide complex (2020-04-28),
11. 10562955 - Polypeptides (2020-02-18),
12. 10556933 - Polypeptide libraries with a predetermined scaffold (2020-02-11),
13. 10364280 - Polypeptide (2019-07-30),
14. 10329331 - Polypeptides (2019-06-25),
15. 10323066 - Neonatal Fc receptor binding dimer and methods of use (2019-06-18),
Affibody AB is a Swedish privately-held biotech company focused on developing next-generation biopharmaceuticals based on its proprietary technology platforms: Affibody® molecules and Albumod™. The company's innovative platforms enable the rapid generation of new drug candidates for diseases with high unmet medical needs, such as cancer, autoimmune and inflammatory diseases. Affibody AB has a strong pipeline of therapeutic programs in both preclinical and clinical stages.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Affibody Ab
41 Patents

#8 in Solna

#172 in Sweden

#16,652 in the World

Solna, SE
Solna, Sweden

Affibody Ab

Forward Citations = 148

55 inventors:

goldMedal Elin Gunneriusson (13 out of 20 patents)

silverMedal Fredrik Frejd (11 out of 12 patents)

bronzeMedal Joachim Feldwisch (10 out of 16 patents)

4.  Christofer Lendel (10 out of 12 patents)

5.  Nina Herne (9 out of 10 patents)

Please report any incorrect information to [email protected]
Loading…